Tasquinimod
正在补全数据,稍后刷新页面可查看最新内容
254964-60-8COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2CONDYALNGTUAJDX-UHFFFAOYSA-NTasquinimod is a quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human prostate cancer xenografts.
安全信息仅供参考,不能替代供应商安全技术说明书(SDS)、适用法规与专业评估。
生产方法实施例8 N-甲基-N-(4-三氟甲基苯基)-1,2-二氢-4-羟基-5-甲氧基-1-甲基-2-氧代喹啉-3-甲酰胺(方法B)的一般步骤:在冰浴条件下,将1,2-二氢-4-羟基-5-甲氧基-1-甲基-2-氧代喹啉-3-羧酸(8g,0.032mol)和三乙胺(15.5ml,0.11mol)溶于10ml二氯甲烷中,冷却至0℃。在0.5小时内,向此溶液中滴加亚硫酰氯(3.0ml,0.042mol)的150ml二氯甲烷溶液,同时保持温度在4℃。滴加完毕后,继续在4℃下搅拌4小时。反应完成后,用10ml二氯甲烷稀释反应混合物,依次用冷的1M硫酸和1M氢氧化钠溶液洗涤。将水相的pH调节至8-8.5,过滤澄清后,用盐酸酸化至pH4。静置后,结晶沉淀形成,过滤收集沉淀,用水洗涤并干燥,得到目标产物4-羟基-5-甲氧基-N,1-二甲基-2-氧代-N-(4-(三氟甲基)苯基)-1,2-二氢喹啉-3-甲酰胺(8.5g,产率65%)。产物经1H NMR和13C NMR确认结构,并进行了ESI MS/MS分析。参考文献:[1] Patent: US6133285, 2000, A[2] Patent: EP1095021, 2003, B1. Location in patent: Page/Page column 9
254964-60-8DTXSID90180183CHEMBL2107784CHEBI:231355